Toviaz (U.S. Pharmaceuticals)


Welcome to the PulseAid listing for the Toviaz drug offered from U.S. Pharmaceuticals. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: U.S. Pharmaceuticals
NON-PROPRIETARY NAME: fesoterodine fumarate
SUBSTANCE NAME: FESOTERODINE FUMARATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-10-31
END MARKETING DATE: 0000-00-00


Toviaz HUMAN PRESCRIPTION DRUG Details:

Item DescriptionToviaz from U.S. Pharmaceuticals
LABELER NAME: U.S. Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 8(mg/1)
START MARKETING DATE: 2008-10-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63539-183_47f19c39-9fd2-4471-9d91-08da92d4fb68
PRODUCT NDC: 63539-183
APPLICATION NUMBER: NDA022030

Other FESOTERODINE FUMARATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalToviaz
Cardinal HealthToviaz
Pfizer Laboratories Div Pfizer IncToviaz
Physicians Total Care, Inc.Toviaz
U.S. PharmaceuticalsToviaz